Hotels in Orlando

If you are thinking of attending this event, we are here to help you out. We offer luxurious, affordable and best hotel accommodation nearest to the venue of the conference. So, pack your bags for AACR 2023.

Individual Hotel Booking

If you are a solo traveler or individual attendee planning to attend the AACR 2023, we ensure to take care of your whole trip - from lodging to exploring the city of Orlando making it delightfully.

Register here

From basic findings to latest advancements in Advancing Cancer Research, the meeting will bring educational collaborations in Advancing Cancer research. Don't wait to register AACR 2023

Welcome to AACR Annual Meeting 2023

Welcome to the AACR website

AACR 2023 is going to be beginning on 14 April and ending on 19 April 2023. AACR 2023 is truly an amazing Meeting which will cover the topics of Medical, Health Care, Oncology, Cancer, Cancer Treatment and Cancer Diagnosis and much more. It will be a marvelous Medical and Cancer Treatment and Cancer Diagnosis Meeting at Orange County Convention Center Orlando, Florida.

The AACR was founded in 1907 by a group of 11 physicians and scientists interested in research, "to further the investigation and spread the knowledge of cancer." Today, the AACR accelerates progress toward the prevention and cure of cancer by promoting research, education, communication, and collaboration.

Annual Meeting of the American Association for Cancer Research is organized annually. The annual meeting continues to grow! It will be expected to reach 26000 attendees this year.

Key Dates
• September 20, 2022: Membership Application Deadline for Early Access to Housing Reservations
• September 27, 2022: Abstract Submission Opens
• September 27, 2022: Early Access to Housing Reservations Opens for Members
• November 17, 2022: Regular Abstract Submission Deadline
• January 12, 2023: Late-Breaking and Clinical Trials Abstract Submission Deadline

We look forward to welcome you to Orlando! Book Your Hotel Now.

Venue

Worldwide Participants

Dates to Remember

Accommodation For AACR 2023

Book Soon with us…Limited Rooms Available

We offer great deals of accommodation in the best hotels of Orlando and that too within the vicinity of the conference center. Luxurious hotels ranging from 2 to 5-star with huge discounts are available near the Orange County Convention Center Orlando, Florida, USA. Book with us and get immediate confirmation of your hotel reservation.
You may reserve your rooms as per group as well as individual.

Group Hotel Booking

Book online. We will get back to you
as soon as possible.

Online Registration Form for AACR 2023

Online Registration Form

 Also Get the Hotel Options Near Convention Center

Venue for AACR 2023

Orlando, USA

From its towering skyscrapers to the sweeping arc of its expansive lakeshore, there's a feeling of confidence and pride that radiates from the landmark features of Orlando and from the faces of the city's inhabitants as well. The Windy City embodies the values of the American heartland, and a trip to Orlando offer visitors the chance to see what an American city can accomplish through hard work and determination.

 

Venue

Orange County Convention Center Orlando, Florida

 

Location

Orlando, USA

 

Congress Program

Presenting a clear Technological Perspective

AACR 2023

Program Overview

On Friday, April 08, 2022, a program of Educational Sessions and Methods Workshops will be presented beginning at 3 p.m. The Opening Ceremony and the Opening Plenary Session will take place on Sunday morning, April 11. The meeting will conclude at 1:30 p.m. on Wednesday, April 13. The 2022 Program in Progress follows. 
Educational Sessions
Methods Workshops
Plenary Sessions
Major Symposia
Meet-the-Expert Sessions
Advances in Diagnostics and Therapeutics
Advances in Organ Site Research
Advances in Prevention and Interception
Advances in the Science of Cancer Health Disparities
Forums

Educational Sessions

Approaches for Utilizing the Microbiome in Cancer Epidemiology Research
Biomarker Studies: Study Design and Statistical Considerations
CAR-T Therapy State of the Art
Characterizing Cancer Disparities Nationally and Internationally Using Publicly Available Data
Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
Chemistry to the Clinic: Part 2: Novel Chemical Tools and Leads for Unprecedented Targets
Chemistry to Clinic: Part 3: Unconventional Modalities to Extend the Antitumor Target Space
Co-Evolution of Tumor and Microenvironment in Cancer Metastasis
Convergence
Developing Standardized Platforms for Immune Monitoring in Cancer Immunotherapy Clinical Trials
Diverse Functions of Neutrophils in Cancer
Drug Development in China/Asia
The Endothelium and Fluid Flows: Linking Metastasis and Immunity
The Evolution of the Art and Science of Go/No Go Decisions in Cancer Drug Development
Extracellular Vesicles and Intercellular Communication in Cancer
FDA Session on Introduction to Oncology Drug Regulation
FDA Session on Topics in Oncology Regulation
Fibroblasts in the Driver's Seat: Impact on Tumor Progression and Therapy Resistance
Fluorescence Image-Guided Surgery for Improved Clinical Outcomes
From Cancer Genomics to the 3D Organization of the Genome
Genetic Predispositions to Childhood Lekemias: Implications for Pathogenesis and Screening
Host Versus Tumor Autophagy in Cancer
Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
Integrating Tumor Immunology and Molecular Epidemiology
Intersection of Radiation and Immune Therapy
Liquid Biopsies for Early Detection of Cancer
Metabolic Drivers of Cancer
Modulation of the Gut Microbiome to Treat Dysbiosis and Cancer
Molecular Regulation of Cancer Inflammation, Progression and Treatment Resistance
Obesity: Local and Systemic Inflammation Affecting Cancer
Oncolytic Virus Therapy
Ordering Genomic Changes as Actionable Targets in Pediatric Cancers
Organoids as Model Systems in Cancer
Pancreatic Tumor Microenvironment
Pathology 101
Personalized Circulating Tumor DNA Analysis for Minimal Residual Disease Detection
Precision Medicine in 2022
Preleukemia and Clonal Hematopoiesis
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Resistance to Therapies and Cancer Cell Dormancy
Single Cell and Spatial Genomics
Stromal Niches for Organ-Tropic Metastasis
Systems Biology Approaches to Cancer
Targeting Cancer Neoantigens
Tools for Machine Learning in Cancer Image Analysis
Tumor Immunology and Immunotherapy for Nonimmunologists: Roundtable Discussions
Tumor Immunology and Immunotherapy for Nonimmunologists: Standard Cancer Therapies are Ultimately Immunotherapies
Update on Young Women’s Breast Cancer
Vascular-Immune Cell Cross Talk: Implications for Cancer Immunotherapy

Methods Workshops

Circulating Cell Free DNA to Guide Prostate Cancer Treatment with PARP
Clinical Trial Design: Part 1: The ABCs of Doing Cancer Clinical Trials
Clinical Trial Design: Part 2: Novel Trial Designs
Clinical Trial Design: Part 3: Biomarker-Directed Clinical Trials
Clinical Trial Design: Part 4
Controversies in Replication cfDNA Measurements
Deciphering and Targeting Lysosomes in Cancer
Defining the Significance of BRCA1 Variants of Unknown Significance
Defining Tumor Organ-systems with Single Cell Transcriptomics
Designing Biomarker Studies to Achieve Desired Clinical Applications
Game-Changing Technologies for High Through-Put Functional Characterization of Cancer Gene Variants
Metabolomic Methods for Cancer Research
Methods for Utilizing the Microbiome in Cancer Epidemiology Research
Modeling Tumor Dormancy
Novel Imaging Strategies in the Metastatic Niche
Peering through the Looking Glass: Imaging and the Metastatic Niche
Sample Size and Power Workshop for Basic, Translational, and Clinical Studies

Major Symposia

AACR-Bayard D. Clarkson Symposium: Single-Cell Anaysis of Tumor Heterogeneity
Advancing Epigenetic Therapies for Solid Tumors
Artificial Intelligence and Machine Learning for Regulatory Use
At the Roots of Cancer: Biology and Regulation of the Hippo-YAP Pathway
Blood Biopsy for Response Monitoring
Bone Marrow Sensing of Distant Tumors: From Early Detection to Possible Therapy 
Cell-Based Therapies (Imm7)
The Changing Etiology of Liver Cancer: Needs for Prevention
Characterizing and Managing Cancer as a Complex Adaptive System 
Circadian Rhythms and Cancer
Clinical Trials and Clinical Utility 
Convergence of Artificial Intelligence, Big Data, and Prediction in Cancer
  Deregulation of Histone Modifiers in Cancer
Diverse Populations and Cancer
Earlier Detection of Cancer: Who to Screen, Where to Screen, and What to Screen?
Effects of Systemic Tumor-host Responses in Progression and Therapy Responses
Escaping Immune Surveillance
Evolution and Development of Resistance to Therapy 
FDA Special Session with Richard Pazdur
Genomic Instability
Germline-Somatic Interactions in Cancer Risk and Tumor Evolution 
Hematologic Malignancies
Immune Exhaustion in Cancer Therapies
Impact of a Brexit on Oncology Drug Development and Regulation
Interactions between the Local Microenvironment and the Cancer Cells in Progression and Therapy Responses
Liquid Biopsies: From Validation to Clinical Utility
Mammalian Sirtuins, Energy Bioenergetics, Metabolism, and Carcinogenesis
The Matrix Reloaded: Influences of the Extracellular Matrix on Tumor Progression
Metabolism: The New Kids on the Block in Cancer Care
Metastasis: Evidence and Clinical Implications of Early Dissemination
  The Microbiome as an Orchestrator of Immunity and Cancer Immunotherapy
Minimal Residual Disease: From Bench to Bedside 
Minorities in Cancer Research Scientific Symposium
Molecular Determinants and Dynamics of Metastasis
Multilevel Consideration of Cancer Health Disparities: Contextual Factors to Molecular Features 
The Next Generation of Precision Cancer Medicine:  Recognizing and Exploiting the Complexity
Obesity and Cancer: When Systemic Metabolism Cell Metabolism
Organ-Specific Immunity
Pediatric Oncology: Discovery, Development, Distribution
Prediagnostic Esposures and Tumor Mutational Signatures in Population Studies
Predictive Biomarkers
Presidential Select Symposium: Engaging Cancer Patients as Partners in the Research Process
Recently Approved Breakthrough Therapies and New Approval Endpoints
Regulation and Function of TP53 
Regulatory Considerations for Liquid Biopsy
The Science of Survivorship: Long-term Survivorship in Vulnerable Populations
Systematic Elucidation of Nononogene Targets
Systems Biology and Cancer Immunology
Systems Epigenetics in Hormone-Driven Cancers
  Tobacco Session
Transcriptional and Gene-Regulatory States: How They Relate to Lineage Origin and Plasticity in Pediatric Cancer
Tumor Metabolism and DNA Damage Response
Vascular Regulation of Anti-tumor Immunity

Diagnostics & Therapeutics

Cooperativity of Tumor Clones
Innate Immunity and Complement in Solid Tumors
Intratumoral Approaches to Immunotherapy 
Liquid Biopsy in Brain Tumors and Metastases 
Modeling Treatment Response in Patient-Derived Organoids
  Molecular Imaging 
Nonpharmacologic Approaches to Improving Survival and Patient-Reported Outcomes 
Proton Therapy 
Recent Progress in Boron Neutron Capture Therapy
Regulation of the Immune Microenvironment by Glycosylation
The Remarkable Utility of Proximate Biologic Samples: Molecular Detection of Endometrial Cancer
RNA Editing in Cancer Pathophysiology
Small Molecule Protein Degraders
T-Cell Bispecifics: What Have We Learned About T-Cell Engagers in the Clinic?
Tumor Treating Fields- A Fourth Modality in Cancer Treatment
Vaccines

Organ Site Research

Advances in Brain Metastases 
Advances in Gastric Cancer
Advances in Multiple Myeloma
Advances in Pancreatic Cancer 
Biologic Therapy Advances in Pediatric Tumors
The Changing Face of Ovarian Cancer 
Esophageal Cancer Equal Biology to Translational Medicine
Genetic Predisposition in Hematologic Malignancies
Genitourinary, Bladder, and Renal Cancers
Neuroendocrine Tumors: Genomics, Genetics, and Therapy
Small Cell Lung Cancer: A Glimmer of Light at the End of the Tunnel

Prevention, Interception & Cancer Health Disparities

Advances in Prevention and Interception
Engineering Meets Biology
Role of Chronic Stress in the Etiology of Cancer 
Spectrum of Premalignant and Malignant Genomic Alterations in the “Healthy” Population 
Advances in the Science of Cancer Health Disparities
Novel Applications of Clinical Trials Research to Studying Disparities
The Science of Cancer Health Disparities

Forums

B Cells in Solid Tumors: Good or Bad Biden Cancer Initiative Cancer Imaging: Separating the Hype from the Hope in Radiomics and Machine Learning Challenges and Opportunities of International Consortia The Changing Economics of Cancer Drugging the Undruggable Elimination of HPV and Related Cancers Fighting the IL-1 Inflammatory Pathway The Future of the In Vitro Clinical Test Regulation Immuno-oncology Combination Trials: What Went Wrong? Implementation Science for Evidence-Based Cancer Prevention and Early Detection Practices in Defined Diverse Populations The Integration of Nanotechnologies and Bioengineering for Cancer Research Minorities in Cancer Research Forum The Science of Global Community Outreach Science of Survivorship: The Intersection of Survivorship and Aging Updates on Atlas Development

Meet-the-Experts

A-I DNA Editing in Mutation and Diversity
The ALK Oncogene and Neuroblastoma - Yael P. Mosse, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Amyloidosis - Suzanne Lentzsch, Columbia University, New York, New York
Approaches to Combination Therapy - Peter K. Sorger, Harvard Medical School, Boston, Massachusetts
ATAC Sequencing
Basic Immunology - Adrian Hayday, Francis Crick Institute, London, United Kingdom
Basic Immunology and Cancer Immunobiology
Big Data
Biology of Circulating Tumor Cells in Cancer Metastasis
Biomedical Informatics and Artificial Intellengence
Brain Tumor Biology: Malignant Networks in the Brain, and How to Target Them - Frank A. Winkler, German Cancer Research Center, Heidelberg, Germany
Breast Cancer Stem Cells: Translating Biology to the Clinic - Max S. Wicha, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Chemical Methods to Decipher the Role of Individual Kinases and Their Cellular Signaling Networks
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition - Johann S. DeBono, Institute of Cancer Research, Sutton, United Kingdom
CODEX Multiplex Imaging
Combination Therapies: Immunotherapy and Radiation
Detection, Biology, and Clinical Relevance of CTC Clusters
Developmental Models of Pediatric Brain Tumors - Peter B. Dirks, The Hospital for Sick Children, Toronto, Ontario
Diet, the Gut Microbiome, and Colorectal Cancer - Andrew T. chan, Massachusetts General Hospital, Boston,Mas.
Disparities in Breast Cancer Prevention Research
DNA Repair
Drugging the Undruggable: The Myc Oncogene, as a Case Study
Engaging and Involving Patients in Translational Cancer Research - Bodour Salhia, University of Southern California
High Dimensional Analysis using Mass Cytometry - Kara L. Davis, Stanford University, Stanford, California
Immune Checkpoint Pathways, Melanoma, Surgery
Lung Cancer: Trials - Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Metabolism: PI3K - Lewis C. Cantley, Weill Cornell Medical College, New York- Presbyterian Hospital, New York
Modeling of Pediatric Brain Tumors
Natural Killer Cells
New Single Cell Methods for Oncology and Immuno-oncology - James R. Heath, California Institute of Technology, Pasadena, California
Novel Radiopharmaceuticals for Cancer Diagnosis and  Diagnosis and Therapy, and Methods to Predict and Monitor the Response of  Tumors to Chemotherapy
Novel Therapeutic Strategies in Multiple Myeloma - Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston
Obesity: Changing the Landscape for Cancer Risk in Populations
Prostate Cancer Health Disparity - Timothy R. Rebbeck, Harvard School of Public Health, Boston, Massachusetts
Radiation and Immunotherapy in Breast Cancer
Single Cell Genomics in Cancer to Deconvolute Tumor Heterogeneity
Systems Biology: Experimental and Mathematical, Computational Analysis
Universal Cancer Biomarker - Simple Test Using Gold Nanoparticles that Instantly Change Color to Determine if the 3D Nanostructures of Cancer DNA are Present - Matt Trau, The University of Queensland, Brisbane, Australia
Uses of CRISPR Technology in Translational Cancer Research - René Bernards, Netherlands Cancer Institute, Amsterdam
Using Zebrafish to Model Pediatric Cancer and Identify New Pathways for Targeted Drug Therapy - A. Thomas Look, Dana-Farber Cancer Institute, Boston, Massachusetts
What Cancer Genomes Tell Us About the Origins of Breast Cancer - Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, Illinois
AACR 2023 Orlando

Interested? Let's get in touch!

We would love to assist you regarding
American Association for Cancer Research Annual Meeting 2023
  office@aacr-meeting.org

Disclaimer : The website provides independent information to the visitors about event, venue, dates etc and suggest/book the best hotels and accommodation near the venue to attendees and are not directly associated with any Society. Click Below For Official Website